Status:
UNKNOWN
Diagnostic Significance of CTCs in Patients With Thyroid Nodules (Circulating Tumor Cells)
Lead Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Collaborating Sponsors:
China-Japan Friendship Hospital
Chinese PLA General Hospital
Conditions:
Thyroid Nodule
Diagnoses Disease
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Thyroid nodule patients with suggestion of fine needle aspiration biopsy (FNAB) offered by ultrasound are enrolled in the study. CTCs tested by Optimizing method and FNAB will be performed simultaneou...
Detailed Description
Some retrospective analysises showed CTCs is considered to be valuable for diagnosis, staging, prognosis and follow-up in several types of cancers and some mRNA markers are helpful in differentiating ...
Eligibility Criteria
Inclusion
- patients with thyroid nodules (≤2cm) untreatment FNAB suggested by ultrasound
Exclusion
- the history of other cancer the history of thyroid surgery Bethesda class 3 without surgery
Key Trial Info
Start Date :
July 25 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 20 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03772496
Start Date
July 25 2018
End Date
February 20 2020
Last Update
September 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Hospital, Chinese Academy of Medical Science
Beijing, Beijing Municipality, China, 100021